- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x DKA- ARG- VAL- LYS- AR7- 0QE: DECANOYL-ARG-VAL-LYS-ARG-CHLOROMETHYLKETONE INHIBITOR(Non-covalent)
- 1 x NAG- NAG- BMA- MAN- NAG- GAL- NAG- GAL- MAN- NAG- FUL: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-[beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x CA: CALCIUM ION(Non-covalent)
CA.7: 6 residues within 4Å:- Chain A: D.8, D.55, V.98, N.101, V.103, G.105
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.8, A:D.55, A:V.98, A:V.103, A:G.105
CA.8: 4 residues within 4Å:- Chain A: D.151, D.194, E.224
- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.1
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.151, A:D.194, A:E.224, A:E.224, H2O.8
CA.21: 6 residues within 4Å:- Chain B: D.8, D.55, V.98, N.101, V.103, G.105
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:D.8, B:D.55, B:V.98, B:V.103, B:G.105
CA.22: 3 residues within 4Å:- Chain B: D.151, D.194, E.224
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.151, B:D.194, B:E.224, B:E.224, H2O.22
CA.29: 6 residues within 4Å:- Chain C: D.8, D.55, V.98, N.101, V.103, G.105
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.8, C:D.55, C:V.98, C:V.103, C:G.105
CA.30: 3 residues within 4Å:- Chain C: D.151, D.194, E.224
5 PLIP interactions:2 interactions with chain C, 3 Ligand-Water interactions- Metal complexes: C:D.194, C:E.224, H2O.25, H2O.27, H2O.28
CA.37: 6 residues within 4Å:- Chain D: D.8, D.55, V.98, N.101, V.103, G.105
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.8, D:D.55, D:V.98, D:V.103, D:G.105
CA.38: 3 residues within 4Å:- Chain D: D.151, D.194, E.224
5 PLIP interactions:2 interactions with chain D, 3 Ligand-Water interactions- Metal complexes: D:D.194, D:E.224, H2O.37, H2O.40, H2O.41
- 36 x SO4: SULFATE ION(Non-functional Binders)
SO4.9: 5 residues within 4Å:- Chain A: R.86, H.87, R.90, H.257
- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.1
Ligand excluded by PLIPSO4.10: 1 residues within 4Å:- Chain A: R.86
Ligand excluded by PLIPSO4.11: 7 residues within 4Å:- Chain A: S.387, G.454, T.455
- Chain C: S.387, Y.453, G.454, T.455
Ligand excluded by PLIPSO4.12: 4 residues within 4Å:- Chain A: K.458
- Chain B: E.123, T.125, D.126
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain A: E.123, T.125, D.126
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain A: G.39, N.138, H.141, K.279
Ligand excluded by PLIPSO4.15: 1 residues within 4Å:- Chain A: H.373
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain A: C.253, T.254, E.255, S.256
Ligand excluded by PLIPSO4.17: 3 residues within 4Å:- Chain A: K.154, H.414, Y.416
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain A: P.77, R.78, Y.79
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain A: E.164, Q.381, R.383
- Chain B: E.165
Ligand excluded by PLIPSO4.23: 2 residues within 4Å:- Chain B: K.252, C.253
Ligand excluded by PLIPSO4.24: 5 residues within 4Å:- Chain B: R.86, H.87, R.90, H.257
- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.2
Ligand excluded by PLIPSO4.25: 1 residues within 4Å:- Chain B: R.86
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain B: N.238, Q.239, N.240
Ligand excluded by PLIPSO4.27: 5 residues within 4Å:- Chain A: R.161, E.165
- Chain B: E.164, Q.381, R.383
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain B: C.253, T.254, E.255, S.256
Ligand excluded by PLIPSO4.31: 1 residues within 4Å:- Chain C: R.86
Ligand excluded by PLIPSO4.32: 5 residues within 4Å:- Chain C: R.86, H.87, R.90, H.257
- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.3
Ligand excluded by PLIPSO4.33: 3 residues within 4Å:- Chain C: T.125, D.126
- Chain D: K.458
Ligand excluded by PLIPSO4.34: 5 residues within 4Å:- Chain C: E.164, Q.381, R.383
- Chain D: R.161, E.165
Ligand excluded by PLIPSO4.35: 3 residues within 4Å:- Chain C: Q.251, K.252, C.253
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain C: T.254, E.255, S.256
Ligand excluded by PLIPSO4.39: 2 residues within 4Å:- Chain C: N.138
- Chain D: R.341
Ligand excluded by PLIPSO4.40: 5 residues within 4Å:- Chain C: R.161, E.165
- Chain D: E.164, Q.381, R.383
Ligand excluded by PLIPSO4.41: 4 residues within 4Å:- Chain C: K.458
- Chain D: E.123, T.125, D.126
Ligand excluded by PLIPSO4.42: 2 residues within 4Å:- Chain C: R.341
- Chain D: N.138
Ligand excluded by PLIPSO4.43: 5 residues within 4Å:- Chain D: R.86, H.87, R.90, H.257
- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.4
Ligand excluded by PLIPSO4.44: 1 residues within 4Å:- Chain D: R.86
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain D: H.397, R.405, T.407
Ligand excluded by PLIPSO4.46: 4 residues within 4Å:- Chain D: G.39, N.138, H.141, K.279
Ligand excluded by PLIPSO4.47: 3 residues within 4Å:- Chain D: K.154, H.414, Y.416
Ligand excluded by PLIPSO4.48: 2 residues within 4Å:- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.1, DKA-ARG-VAL-LYS-AR7-0QE.1
Ligand excluded by PLIPSO4.49: 3 residues within 4Å:- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.2, DKA-ARG-VAL-LYS-AR7-0QE.2, DKA-ARG-VAL-LYS-AR7-0QE.2
Ligand excluded by PLIPSO4.50: 3 residues within 4Å:- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.3, DKA-ARG-VAL-LYS-AR7-0QE.3, DKA-ARG-VAL-LYS-AR7-0QE.3
Ligand excluded by PLIPSO4.51: 2 residues within 4Å:- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.4, DKA-ARG-VAL-LYS-AR7-0QE.4
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Henrich, S. et al., The Crystal Structure of the Proprotein Processing Proteinase Furin Explains its Stringent Specificity. Nat.Struct.Biol. (2003)
- Release Date
- 2003-07-08
- Peptides
- Furin precursor: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x DKA- ARG- VAL- LYS- AR7- 0QE: DECANOYL-ARG-VAL-LYS-ARG-CHLOROMETHYLKETONE INHIBITOR(Non-covalent)
- 1 x NAG- NAG- BMA- MAN- NAG- GAL- NAG- GAL- MAN- NAG- FUL: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-[beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x CA: CALCIUM ION(Non-covalent)
- 36 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Henrich, S. et al., The Crystal Structure of the Proprotein Processing Proteinase Furin Explains its Stringent Specificity. Nat.Struct.Biol. (2003)
- Release Date
- 2003-07-08
- Peptides
- Furin precursor: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D